RiverPark Advisors’s RxSight RXST Stock Holding History

RiverPark Advisors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,829	Closed	-$46.2K	–	138
2025 Q1	$46.2K	Sell	1,829 -5,603	-75%	-$167K	0.04%	111
2024 Q4	$171K	Buy	7,432 +2,632	+55%	+$119K	0.14%	88
2024 Q3	$237K	Buy	4,800 +1,421	+42%	+$72.8K	0.19%	76
2024 Q2	$203K	Buy	3,379 +297	+10%	+$17K	0.17%	78
2024 Q1	$159K	Buy	3,082 +2,414	+361%	+$118K	0.13%	84
2023 Q4	$26.9K	Buy	668 +275	+70%	+$8.07K	0.02%	90
2023 Q3	$11K	Buy	+393	New	+$11.7K	0.01%	103

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RiverPark Advisors's RXST Position: Q2 2025 in Review

RiverPark Advisors sold out of RxSight (RXST) in Q2 2025, closing a stake of 1,829 shares — an estimated $46.2K sold.

RiverPark Advisors first reported a position in RXST in Q3 2023 and held it in 7 quarters. The position peaked at $237K in Q3 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

RiverPark Advisors reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
RiverPark Advisors sold 1,829 RxSight shares in Q2 2025, an estimated $46.2K.
RiverPark Advisors first reported a position in RxSight in Q3 2023 and held it in 7 quarters.
RiverPark Advisors's RxSight position peaked at $237K in Q3 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on RiverPark Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.